Potassium Ion

Potassium Ion

SCHEMBL1421665

CC(C)(O)C(=O)[O-].[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9323175 0.92 ALDH1A1 (0.50)
SCHEMBL10458537 0.92 ALDH1A1 (0.50)
Lithium Ion SCHEMBL3855722 0.92
SCHEMBL8167789 0.92 ALDH1A1 (0.50)
SCHEMBL3860699 0.92 ALDH1A1 (0.50)
SCHEMBL5014719 0.92 ALDH1A1 (0.50)
SCHEMBL9322302 0.92 ALDH1A1 (0.50)
SCHEMBL3133203 0.92 ALDH1A1 (0.50)
Silver SCHEMBL8940458 0.92
SCHEMBL10458639 0.92 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1522547-B1 Highly reactive liquid uretdione groups-containing polyurethane systems which are curable at low temperature EVONIK DEGUSSA GMBH (DE) 2009-09-30 EP claimed
WO-2009068377-A1 POLYURETHANE COMPOUNDS CONTAINING URETDIONE GROUPS AND HARDENABLE AT LOW TEMPERATURE AND ALSO CONTAINING ADHESION-IMPROVING RESINS EVONIK DEGUSSA GMBH (DE) 2009-06-04 WO claimed
EP-1844084-A1 HIGHLY REACTIVE URETDIONE GROUP-CONTAINING POLYURETHANE COMPOSITIONS BASED ON 1,4-DIISOCYANATO-DICYCLOHEXYL METHANE Degussa GmbH (DE) 2007-10-17 EP claimed
EP-1799744-A1 HIGHLY REACTIVE POLYURETHANE COMPOSITIONS CONTAINING URETDIONE GROUPS Degussa AG (DE) 2007-06-27 EP claimed
WO-2006069839-A1 HIGHLY REACTIVE URETDIONE GROUP-CONTAINING POLYURETHANE COMPOSITIONS BASED ON 1,4-DIISOCYANATO-DICYCLOHEXYL METHANE DEGUSSA GMBH (DE) 2006-07-06 WO claimed
WO-2006040225-A1 HIGHLY REACTIVE POLYURETHANE COMPOSITIONS CONTAINING URETDIONE GROUPS DEGUSSA AG (DE) 2006-04-20 WO claimed
EP-1522548-A1 Uretdione-group-containing polyurethane compositions which are cross-linkable at low temperatures Degussa AG (DE) 2005-04-13 EP claimed
EP-1522547-A1 Highly reactive liquid uretdione groups-containing polyurethane systems which are curable at low temperature Degussa AG (DE) 2005-04-13 EP claimed
EP-1475400-A1 Solid uretdione groups containing polyurethane powder coatings compositions curable at low temperature Degussa AG (DE) 2004-11-10 EP claimed
EP-2297104-B1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER IP GMBH (DE) 2013-08-07 EP disclosed
EP-2297104-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-03-23 EP disclosed
EP-1658266-B1 PENTAFLUOROSULFANYL PHENYL-SUBSTITUTED BENZOYLGUANIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE AS MEDICAMENTS OR DIAGNOSTIC AGENTS AND MEDICAMENT CONTAINING SAID COMPOUNDS SANOFI AVENTIS DEUTSCHLAND (DE) 2010-08-11 EP disclosed
WO-2009143992-A1 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-12-03 WO disclosed
EP-1522547-B1 Highly reactive liquid uretdione groups-containing polyurethane systems which are curable at low temperature EVONIK DEGUSSA GMBH (DE) 2009-09-30 EP disclosed
EP-1181264-A1 METHOD FOR PRODUCING 2,2,4,4-TETRA-SUBSTITUTED 1,3,5-CYCLOHEXANETRIONES BASF AKTIENGESELLSCHAFT (DE) 2002-02-27 EP disclosed
WO-2001060776-A1 METHOD FOR SYNTHESIZING 2,2,4,4-TETRASUBSTITUTED 1,3,5-CYCLOHEXANE TRIONS BASF AKTIENGESELLSCHAFT (DE) 2001-08-23 WO disclosed
WO-2001017954-A1 BILE ACID-SUBSTITUTED PHENYL-ALKENOYLGUANIDINES, METHOD FOR PRODUCING SAID PHENYL-ALKENOYLGUANIDINES, USE THEREOF AS MEDICAMENTS OR DIAGNOSTIC REAGENTS AND MEDICAMENTS CONTAINING THE SAME AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-03-15 WO disclosed
WO-2000075095-A1 METHOD FOR PRODUCING 2,2,4,4-TETRA-SUBSTITUTED 1,3,5-CYCLOHEXANETRIONES BASF AKTIENGESELLSCHAFT (DE) 2000-12-14 WO disclosed
US-4126428-A MINUTE CAPSULES HAVING PERMEABLE PARTIALLY POLYMERIZED ISOCYANATE WALLS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1978-11-21 US disclosed
US-3963680-A CURING CATALYSTS, POLYFUNCTIONAL AMINE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1976-06-15 US disclosed